Amadeo Sanz-Perez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amadeo Sanz-Perez has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Arantxa Pérez González
Podiatry Department, Faculty of Medicine and Health Sciences, Valencia Catholic University “San Vicente Mártir”, 46001 Valencia, Spain
1 shared publication - Brayan Javier Anaya
Pharmaceutics and Food Technology Department, Faculty of Pharmacy, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
1 shared publication - Cristina Razzano
Doctorate School, Valencia Catholic University “San Vicente Mártir”, 46001 Valencia, Spain
1 shared publication - Cristina Rodríguez-Grande
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain
1 shared publication - Darío García de Viedma
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón
1 shared publication - Dolores Remedios Serrano
Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
1 shared publication
Latest Publications
- Open Access
- 12 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 616
Gastrocnemius Recession in Recalcitrant Plantar Fasciitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Recalcitrant plantar fasciitis (RPF) is a common cause of chronic heel pain, resistant to conservative treatment in up to 10% of cases. A biomechanical association exists between isolated gastrocnemius contracture and increased tension on the plantar fascia. In this context, gastrocnemius recession (GR) has emerged as a surgical intervention aimed at reducing fascial strain and improving functional outcomes. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD420251028862). Randomized controlled trials evaluating the efficacy of GR in patients with RPF were included. Searches were performed in PubMed, Cochrane Library, and Web of Science. Risk of bias was assessed using the RoB 2 tool, and the certainty of evidence was evaluated using the GRADE approach. Primary outcomes included foot function (AOFAS), pain (VAS), and ankle dorsiflexion range (FDTPA). Results: Five studies encompassing 150 patients were included. Meta-analysis revealed statistically significant improvements in foot function (AOFAS, standardized mean difference [SMD] = 0.81; 95% CI: 0.26–1.36), pain reduction (VAS, SMD = −1.17; 95% CI: −1.99 to −0.36), and ankle dorsiflexion (FDTPA, SMD = 0.74; 95% CI: 0.26–1.22). GR demonstrated advantages over plantar fasciotomy in terms of postoperative recovery and preservation of fascial structure. No major complications were reported, and some studies documented sustained benefits up to six years postoperatively. Moderate to high heterogeneity was observed, largely due to variations in surgical technique and follow-up durations. Conclusions: Gastrocnemius recession is a safe and effective surgical option for treating RPF, particularly in patients with isolated gastrocnemius contracture and failure of conservative therapies. It significantly improves foot function, reduces pain, and enhances ankle mobility, with durable long-term outcomes. Trial Registration: This systematic review is registered with PROSPERO (CRD420251028862).
- 12 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 616
Open AccessGastrocnemius Recession in Recalcitrant Plantar Fasciitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Recalcitrant plantar fasciitis (RPF) is a common cause of chronic heel pain, resistant to conservative treatment in up to 10% of cases. A biomechanical association exists between isolated gastrocnemius contracture and increased tension on the plantar fascia. In this context, gastrocnemius recession (GR) has emerged as a surgical intervention aimed at reducing fascial strain and improving functional outcomes. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD420251028862). Randomized controlled trials evaluating the efficacy of GR in patients with RPF were included. Searches were performed in PubMed, Cochrane Library, and Web of Science. Risk of bias was assessed using the RoB 2 tool, and the certainty of evidence was evaluated using the GRADE approach. Primary outcomes included foot function (AOFAS), pain (VAS), and ankle dorsiflexion range (FDTPA). Results: Five studies encompassing 150 patients were included. Meta-analysis revealed statistically significant improvements in foot function (AOFAS, standardized mean difference [SMD] = 0.81; 95% CI: 0.26–1.36), pain reduction (VAS, SMD = −1.17; 95% CI: −1.99 to −0.36), and ankle dorsiflexion (FDTPA, SMD = 0.74; 95% CI: 0.26–1.22). GR demonstrated advantages over plantar fasciotomy in terms of postoperative recovery and preservation of fascial structure. No major complications were reported, and some studies documented sustained benefits up to six years postoperatively. Moderate to high heterogeneity was observed, largely due to variations in surgical technique and follow-up durations. Conclusions: Gastrocnemius recession is a safe and effective surgical option for treating RPF, particularly in patients with isolated gastrocnemius contracture and failure of conservative therapies. It significantly improves foot function, reduces pain, and enhances ankle mobility, with durable long-term outcomes. Trial Registration: This systematic review is registered with PROSPERO (CRD420251028862).
- Open Access
- 8 July 2025
- Published by Springer Nature in Research Square
Reducing delays in the genomic epidemiology of tuberculosis: a flexible and decentralized analysis of each incident case
Background Genomic analysis has enhanced our understanding of Mycobacterium tuberculosis (MTB) transmission. Short-read sequencing in reference labs ensures full population coverage but delays local data access. We assessed a case-by-case genomic approach using primary cultures from each incident case. Methods We prospectively evaluated 53 TB cases in Almeria, Spain, over two periods: 4 months (March–July 2023) for solid (LJ, 23 cases) and 9 months (April–December 2024) for liquid (MGIT, 30 cases) cultures. DNA was purified from LJ when sufficient growth was observed and from MGIT at positivity. Nanopore sequencing was performed on 1–4 cases per run, with flow-cells reused up to six times. Results In 74% of LJ, adequate growth was reached within 21 days. All LJ cultures achieved optimal genome coverage (> 90% at > 20X), 61% with runs under 2.5 hours. Nearly all MGIT cultures, analyzed at positivity (all but six within 21 days), achieved optimal coverage, despite interfering DNA. Four cases had slightly lower but acceptable coverage (73–88%, > 20X). Same-day classification as clustered or orphan was possible. Nanopore sequencing correlated with high-throughput short-read data, enabling quicker correction of epidemiological errors and identification of transmission links. Conclusions Our strategy offers a flexible, rapid decentralized alternative, accelerating cluster information contact tracing.
- 8 July 2025
- Published by Springer Nature in Research Square
Open AccessReducing delays in the genomic epidemiology of tuberculosis: a flexible and decentralized analysis of each incident case
Background Genomic analysis has enhanced our understanding of Mycobacterium tuberculosis (MTB) transmission. Short-read sequencing in reference labs ensures full population coverage but delays local data access. We assessed a case-by-case genomic approach using primary cultures from each incident case. Methods We prospectively evaluated 53 TB cases in Almeria, Spain, over two periods: 4 months (March–July 2023) for solid (LJ, 23 cases) and 9 months (April–December 2024) for liquid (MGIT, 30 cases) cultures. DNA was purified from LJ when sufficient growth was observed and from MGIT at positivity. Nanopore sequencing was performed on 1–4 cases per run, with flow-cells reused up to six times. Results In 74% of LJ, adequate growth was reached within 21 days. All LJ cultures achieved optimal genome coverage (> 90% at > 20X), 61% with runs under 2.5 hours. Nearly all MGIT cultures, analyzed at positivity (all but six within 21 days), achieved optimal coverage, despite interfering DNA. Four cases had slightly lower but acceptable coverage (73–88%, > 20X). Same-day classification as clustered or orphan was possible. Nanopore sequencing correlated with high-throughput short-read data, enabling quicker correction of epidemiological errors and identification of transmission links. Conclusions Our strategy offers a flexible, rapid decentralized alternative, accelerating cluster information contact tracing.
- Open Access
Origanum vulgare ssp. hirtum: From Plant to 3D-Printed Gummies with Antioxidant and Anti-Inflammatory Properties
This study investigates the phytochemical profile, antioxidant and anti-inflammatory properties, and 3D-printing application of Origanum vulgare L. ssp. hirtum extract. The extract revealed a diverse range of phenolic compounds, with rosmarinic acid as the predominant compound (47.76%). The extract showed moderate to high lipoxygenase inhibition (IC50 = 32.0 µg/mL), suggesting its potential as an anti-inflammatory agent. It also exhibited strong antioxidant activity, with hydrogen peroxide scavenging (SC50 = 99.2 µg/mL) and hydroxyl radical scavenging (IC50 = 64.12 µg/mL) capabilities. In cellular studies, high concentrations (50 µg/mL and 100 µg/mL) significantly decreased intracellular ROS production in Caco-2 cells (reductions exceeding 53% and 64%, respectively). Moreover, the extract suppressed NO production in LPS-stimulated J774A.1 macrophages in a concentration-dependent manner. The study also explores the incorporation of the extract into 3D-printed gummies. The gels exhibited a shear-thinning behavior, which was essential for successful extrusion-based 3D printing. The incorporation of Origanum extract significantly influenced the mechanical strength and compaction properties of the 3D-printed gummies before breaking (1.6-fold increase) allowing for a better mouth feeling. PXRD and FTIR analyses confirmed the amorphous nature of the 3D-printed gummies and the interaction between active ingredients and excipients utilized for printing. These findings demonstrated the potential for semisolid extrusion 3D printing at room temperature to transform a culinary herb (Origanum vulgare spp. hirtum) into a healthcare product with antioxidant and anti-inflammatory properties.
Open AccessOriganum vulgare ssp. hirtum: From Plant to 3D-Printed Gummies with Antioxidant and Anti-Inflammatory Properties
This study investigates the phytochemical profile, antioxidant and anti-inflammatory properties, and 3D-printing application of Origanum vulgare L. ssp. hirtum extract. The extract revealed a diverse range of phenolic compounds, with rosmarinic acid as the predominant compound (47.76%). The extract showed moderate to high lipoxygenase inhibition (IC50 = 32.0 µg/mL), suggesting its potential as an anti-inflammatory agent. It also exhibited strong antioxidant activity, with hydrogen peroxide scavenging (SC50 = 99.2 µg/mL) and hydroxyl radical scavenging (IC50 = 64.12 µg/mL) capabilities. In cellular studies, high concentrations (50 µg/mL and 100 µg/mL) significantly decreased intracellular ROS production in Caco-2 cells (reductions exceeding 53% and 64%, respectively). Moreover, the extract suppressed NO production in LPS-stimulated J774A.1 macrophages in a concentration-dependent manner. The study also explores the incorporation of the extract into 3D-printed gummies. The gels exhibited a shear-thinning behavior, which was essential for successful extrusion-based 3D printing. The incorporation of Origanum extract significantly influenced the mechanical strength and compaction properties of the 3D-printed gummies before breaking (1.6-fold increase) allowing for a better mouth feeling. PXRD and FTIR analyses confirmed the amorphous nature of the 3D-printed gummies and the interaction between active ingredients and excipients utilized for printing. These findings demonstrated the potential for semisolid extrusion 3D printing at room temperature to transform a culinary herb (Origanum vulgare spp. hirtum) into a healthcare product with antioxidant and anti-inflammatory properties.